BRIEF-Celgene says 2020 Revlimid forecast is conservative: conf call
April 28, 2016 at 10:22 AM EDT
April 28 (Reuters) - Celgene Execs Say Otezla Continues To Grow At Similar Rate After Novartis' Cosentyx Launch - Conf Call
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.